Latham Takes Boston Scientific to $1.16B Silk Road Acquisition Law360

Latham Takes Boston Scientific to $1.16B Silk Road Acquisition Law360

Boston Scientific to acquire Silk Road Medical for $1.16 billion

Boston Scientific Corp. has announced its acquisition of medical device maker Silk Road Medical Inc. in a deal valued at approximately $1.16 billion.

Wilson Sonsini represents Silk Road Medical

Wilson Sonsini has represented Silk Road Medical in the acquisition deal. The agreement is subject to customary closing conditions, including regulatory approvals, and is expected to be completed in the second half of 2021.

Boston Scientific expands its portfolio with Silk Road Medical

Boston Scientific Corp. is a leading manufacturer of medical devices used in various applications including cardiology, endoscopy, and urology. The acquisition of Silk Road Medical, a company specializing in minimally invasive medical devices for the treatment of vascular conditions like atherosclerotic blockages, will expand Boston Scientific’s already vast portfolio.

Silk Road Medical’s innovative products

Silk Road Medical’s flagship product is the ENROUTE® Transcarotid Neuroprotection System, which safely reverses blood flow away from the brain during carotid stenting procedures to reduce the risk of stroke. The company’s other products include the ENROUTE® Transcarotid Stent System and the ENROUTE® Transcarotid Peripheral Access Kit. These devices have unique features that make them more effective and efficient than traditional medical devices of their kind.

Future benefits of the acquisition

The acquisition is expected to benefit both Boston Scientific Corp. and Silk Road Medical Inc. by combining the former’s extensive resources and distribution channels with the latter’s innovative products and expertise in developing minimally invasive devices for vascular procedures.

The healthcare industry

The healthcare industry continues to evolve with the development of new medical technologies. Companies such as Boston Scientific and Silk Road Medical are at the forefront of this industry, providing healthcare professionals with the tools necessary to improve the outcomes of their procedures, reduce risks to patients, and ultimately save lives.

Long-tail Keywords

Boston Scientific

Silk Road Medical

Medical Devices

Minimally Invasive Devices

ENROUTE® Transcarotid Neuroprotection System

Carotid Stenting Procedures

Stroke Prevention

Originally Post From https://www.law360.com/healthcare-authority/deals-corporate-governance/articles/1849048/latham-leads-boston-scientific-on-1-16b-silk-road-deal

Read more about this topic at
Boston Scientific Announces Agreement to Acquire Silk …
Silk Road Medical Announces Definitive Agreement to be …

Mika Health AstraZeneca and Daiichi Sankyo Partner to Offer AI-Powered Assistance for Healthcare Industry

Dr Hantel Discusses Socioeconomic Factors Affecting AML Treatment on OncLive